Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1977 Feb;36(1):80-2.
doi: 10.1136/ard.36.1.80.

Multicentre trial of naproxen and phenylbutazone in acute gout

R A Sturge, J T Scott, E B Hamilton, S P Liyanage, A S Dixon, J Davies, C Engler
Comparative Study

Multicentre trial of naproxen and phenylbutazone in acute gout

R A Sturge et al. Ann Rheum Dis. 1977 Feb.

Abstract

Naproxen 750 mg as a single dose followed by 250 mg three times daily has been compared with phenylbutazone 200 mg four times daily for 48 hours followed by 200 mg three times daily for treatment of acute gout in an open study on 41 patients. The drugs were equally effective with few and relatively mild side effects. Naproxen is a useful alternative agent for the treatment of acute gout.

PubMed Disclaimer

References

    1. Scand J Rheumatol Suppl. 1973;2:159-63 - PubMed
    1. Ann Rheum Dis. 1974 Jan;33(1):12-9 - PubMed
    1. Q J Med. 1973 Apr;42(166):387-401 - PubMed
    1. J Rheumatol. 1974 Jun;1(2):222-9 - PubMed
    1. Arthritis Rheum. 1974 Mar-Apr;17(2):143-8 - PubMed

Publication types